abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

11 Oct 2004

Author:
Anand Grover, Affordable Medicines Treatment Campaign

Letter from the Affordable Medicines Treatment Campaign to India’s National Human Rights Commission

...introduction of product patent in India will reduce the accessibility and availability of medicines...Certain flexibility available under the TRIPS [Agreement on Trade-Related Aspects of Intellectual Property Rights] should be used to its full extent to safeguard accessibility and availability of drugs and medicines. The Bill, however, fails to make use of this flexibility... [refers to Novartis]